252 related articles for article (PubMed ID: 18757301)
21. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
22. Absence of the p53 tumor suppressor gene promotes osteogenesis in mesenchymal stem cells.
Tataria M; Quarto N; Longaker MT; Sylvester KG
J Pediatr Surg; 2006 Apr; 41(4):624-32; discussion 624-32. PubMed ID: 16567167
[TBL] [Abstract][Full Text] [Related]
23. In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo.
Song IH; Caplan AI; Dennis JE
J Orthop Res; 2009 Jul; 27(7):916-21. PubMed ID: 19137580
[TBL] [Abstract][Full Text] [Related]
24. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
25. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.
Morigi M; Introna M; Imberti B; Corna D; Abbate M; Rota C; Rottoli D; Benigni A; Perico N; Zoja C; Rambaldi A; Remuzzi A; Remuzzi G
Stem Cells; 2008 Aug; 26(8):2075-82. PubMed ID: 18499895
[TBL] [Abstract][Full Text] [Related]
26. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
Miwa S; Mizokami A; Keller ET; Taichman R; Zhang J; Namiki M
Cancer Res; 2005 Oct; 65(19):8818-25. PubMed ID: 16204052
[TBL] [Abstract][Full Text] [Related]
27. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells.
Zhang ZY; Teoh SH; Chong MS; Schantz JT; Fisk NM; Choolani MA; Chan J
Stem Cells; 2009 Jan; 27(1):126-37. PubMed ID: 18832592
[TBL] [Abstract][Full Text] [Related]
28. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity.
Keller ET; Brown J
J Cell Biochem; 2004 Mar; 91(4):718-29. PubMed ID: 14991763
[TBL] [Abstract][Full Text] [Related]
30. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
Chen MY; Lie PC; Li ZL; Wei X
Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
[TBL] [Abstract][Full Text] [Related]
31. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
32. A novel strategy incorporated the power of mesenchymal stem cells to allografts for segmental bone tissue engineering.
Zou XH; Cai HX; Yin Z; Chen X; Jiang YZ; Hu H; Ouyang HW
Cell Transplant; 2009; 18(4):433-41. PubMed ID: 19622230
[TBL] [Abstract][Full Text] [Related]
33. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles.
Hall B; Andreeff M; Marini F
Handb Exp Pharmacol; 2007; (180):263-83. PubMed ID: 17554513
[TBL] [Abstract][Full Text] [Related]
34. In vivo bioluminescence imaging study to monitor ectopic bone formation by luciferase gene marked mesenchymal stem cells.
Olivo C; Alblas J; Verweij V; Van Zonneveld AJ; Dhert WJ; Martens AC
J Orthop Res; 2008 Jul; 26(7):901-9. PubMed ID: 18271011
[TBL] [Abstract][Full Text] [Related]
35. Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells.
Djouad F; Bony C; Apparailly F; Louis-Plence P; Jorgensen C; Noël D
Transplantation; 2006 Oct; 82(8):1060-6. PubMed ID: 17060855
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q
J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144
[TBL] [Abstract][Full Text] [Related]
37. Cbfb enhances the osteogenic differentiation of both human and mouse mesenchymal stem cells induced by Cbfa-1 via reducing its ubiquitination-mediated degradation.
Lien CY; Lee OK; Su Y
Stem Cells; 2007 Jun; 25(6):1462-8. PubMed ID: 17379770
[TBL] [Abstract][Full Text] [Related]
38. Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model.
Fritz V; Louis-Plence P; Apparailly F; Noël D; Voide R; Pillon A; Nicolas JC; Müller R; Jorgensen C
Bone; 2007 Apr; 40(4):1032-40. PubMed ID: 17251073
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow mesenchymal stem cells form ectopic woven bone in vivo through endochondral bone formation.
Chang SC; Tai CL; Chung HY; Lin TM; Jeng LB
Artif Organs; 2009 Apr; 33(4):301-8. PubMed ID: 19335406
[TBL] [Abstract][Full Text] [Related]
40. Dual luciferase labelling for non-invasive bioluminescence imaging of mesenchymal stromal cell chondrogenic differentiation in demineralized bone matrix scaffolds.
Vilalta M; Jorgensen C; Dégano IR; Chernajovsky Y; Gould D; Noël D; Andrades JA; Becerra J; Rubio N; Blanco J
Biomaterials; 2009 Oct; 30(28):4986-95. PubMed ID: 19539363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
